John Ryan - Jul 12, 2021 Form 3 Insider Report for Unicycive Therapeutics, Inc. (UNCY)

Role
Director
Signature
/s/ John Ryan
Stock symbol
UNCY
Transactions as of
Jul 12, 2021
Transactions value $
$0
Form type
3
Date filed
7/12/2021, 05:15 PM
Next filing
Nov 9, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding UNCY Common Stock 58.1K Jul 12, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding UNCY Employee Stock Option (right to buy) Jul 12, 2021 Common Stock 11.6K $0.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of stock options vested on August 1, 2019, and the remaining seventy-five percent (75%) of the stock options have vested and will continue to vest in successive equal monthly installments over the following thirty-six (36) months, until the options become fully vested on August 1, 2022.